Levin O S, Moseĭkin I A
Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(10):30-5.
An open controlled study of efficacy of the vitamin B complex (milgamma) has been performed in 38 patients with vertebrogenic lumbosacral radiculopathy suffered from moderate or severe pain during 1 month or longer. Patients have been randomized into 2 equal groups: in the main group milgamma has been prescribed in the combination with diclofenac; patients of the control group have received diclofenac only. Treatment efficacy has been assessed by clinical scales in the 10th and 24th days, and by the results of telephone interview after 3 and 6 months. A trend to higher efficacy of the treatment of the main group compared to that of the control group assessed with the Visual Analogue Scale was observed during all the study but the difference reached the level of statistical significance only to the 24th day. The assessment of qualitative characteristics of pain with the Neuropathic Pain Scale revealed decreasing of intensive, acute and sensitive pain only in patients of the main group. The moderate or substantial improvement was noted in 66% patients received the combination therapy and only in 34% patients received diclofenac. At the 3rd months, between-group differences were still significant (the pain was absent or minimal in 63% patients of the main group and 34% of the control one). The results revealed the potentiation of analgesic effect of diclofenac by the vitamin B complex. Using of milgamma in combination with NSAIDS leads to the rapid and long-standing regress of pain syndrome in patients with lumbosacral radiculopathy.
对38例患有中度或重度疼痛持续1个月及以上的脊椎源性腰骶神经根病患者进行了复合维生素B(弥可保)疗效的开放性对照研究。患者被随机分为两组:主要组患者服用弥可保并联合双氯芬酸;对照组患者仅接受双氯芬酸治疗。在第10天和第24天通过临床量表评估治疗效果,并在3个月和6个月后通过电话访谈结果进行评估。在整个研究过程中,观察到主要组的治疗效果与对照组相比有更高的趋势,使用视觉模拟量表评估,但差异仅在第24天达到统计学意义水平。用神经病理性疼痛量表评估疼痛的定性特征发现,仅主要组患者的强烈、急性和敏感疼痛有所减轻。接受联合治疗的患者中有66%出现中度或显著改善,而仅接受双氯芬酸治疗的患者中这一比例为34%。在第3个月时,组间差异仍然显著(主要组63%的患者疼痛消失或轻微,对照组为34%)。结果显示复合维生素B可增强双氯芬酸的镇痛效果。弥可保与非甾体抗炎药联合使用可使腰骶神经根病患者的疼痛综合征迅速且长期缓解。